DNA-damaging autoantibodies and cancer: the lupus butterfly theory

Nat Rev Rheumatol. 2016 Jul;12(7):429-34. doi: 10.1038/nrrheum.2016.23. Epub 2016 Mar 24.


Autoantibodies reactive against host DNA are detectable in the circulation of most people with systemic lupus erythematosus (SLE). The long-held view that antibodies cannot penetrate live cells has been disproved. A subset of lupus autoantibodies penetrate cells, translocate to nuclei, and inhibit DNA repair or directly damages DNA. The result of these effects depends on the microenvironment and genetic traits of the cell. Some DNA-damaging antibodies alone have little impact on normal cells, but in the presence of other conditions, such as pre-existing DNA-repair defects, can become highly toxic. These findings raise new questions about autoimmunity and DNA damage, and reveal opportunities for new targeted therapies against malignancies particularly vulnerable to DNA damage. In this Perspectives article, we review the known associations between SLE, DNA damage and cancer, and propose a theory for the effects of DNA-damaging autoantibodies on SLE pathophysiology and cancer risk.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Antinuclear / immunology
  • Autoantibodies / immunology*
  • Autoimmunity / immunology
  • Biomarkers / blood
  • DNA Damage / immunology*
  • Humans
  • Lupus Erythematosus, Systemic / immunology*
  • Lupus Erythematosus, Systemic / pathology
  • Lupus Erythematosus, Systemic / physiopathology
  • Neoplasms / immunology*
  • Neoplasms / pathology
  • Neoplasms / physiopathology


  • Antibodies, Antinuclear
  • Autoantibodies
  • Biomarkers